Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults with Asthma on Medium-to-High Dose Inhaled Corticosteroids

Trial Identifier: D2912C00003
Sponsor: AstraZeneca
Start Date: March 2021
Primary Completion Date: July 2023
Study Completion Date: July 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German (Germany) Translation
English (Australian) Translation
English (Canada) Translation
English (UK) Translation
Spanish (Spain) Translation
French (Canada) Translation
Hungarian (Hungary) Translation
Korean (South Korea) Translation
Polish (Poland) Translation
Ukrainian (Ukraine) Translation
Traditional Chinese (Taiwan) Translation

Trial Locations

Country Location
AU Herston, AU, 4006
AU Melbourne, AU, IC 3004
AU Nedlands, AU, 6009
CA, ON Windsor, ON, CA, N8X 1T3
CA, QC Quebec, QC, CA, G1G 4A2
DE Berlin, DE, 10717
DE Berlin, DE, 10119
DE Berlin, DE, 14050
DE Berlin, DE, 10625
DE Bonn, DE, 53119
DE Frankfurt, DE, 60596
DE Hamburg, DE, 20354
DE Hannover, DE, D-30173
DE Lübeck, DE, 23552
ES Barcelona, ES, 08916
ES Villarreal, ES, 12540
GB High Wycombe, GB, HP11 2QW
GB Liverpool, GB, L7 8XP
GB London, GB, SE1 9RT
GB London, GB, W1G 8HU
HU Csorna, HU, 9300
HU Szombathely, HU, 9700
KR Cheongiu, KR, 28644
KR Incheon, KR, 21431
KR Namdong-gu, KR, 21565
KR Seoul, KR, 03312
KR Seoul, KR, 08308
KR Seoul, KR, 02841
KR Seoul, KR, 06591
KR Suwon-si, KR, 16499
PL Białystok, PL, 15-044
PL Krakow, PL, 30-033
PL Krakow, PL, 31-501
PL Lodz, PL, 90-302
PL Lubin, PL, 59-300
PL Sopot, PL, 81-741
PL Wrocław, PL, 53-301
TW Kaohsiung, TW, 807
UA Kiev, UA, 02000